Tottori University Hospital

Tottori 683-8504

3 studies enrolling now · 10 studies all time

What they study most

C-Met Exon 14 Mutation, Chronic Hypoparathyroidism, Endocrine System Diseases, Heart Failure, Hypochondroplasia, Multiple Myeloma, Ovarian Cancer, Parathyroid Diseases, Sarcoma, Solid Tumors

Studies at this site

• A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months — Recruiting now
• Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer — Recruiting now
• A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide — Running, not enrolling
• Screening Study for Participants With Malignant Tumors — Completed
• Interventional Study of Vosoritide for the Treatment of Children With Hypochondroplasia — Running, not enrolling
• Evaluation of the Safety and Efficacy of Eneboparatide (AZP-3601) in Patients With Chronic Hypoparathyroidism — Running, not enrolling
• Long-Term Extension Study of Vosoritide to Treat Children With Hypochondroplasia — Enrolling by invitation
• REDUCE LAP-HF TRIAL II — Running, not enrolling
• Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer — Completed
• Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer — Completed